FDA Advisers Say 'No' to Myeloma Drug

(MedPage Today) -- Oncologic Drugs Advisory Committee voted against panobinostat for relapsed or refractory myeloma. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1xlG49M